Australia markets open in 1 hour 24 minutes

ABBV Jan 2024 200.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
60.74-0.88 (-1.43%)
As of 10:29AM EST. Market open.
Full screen
Previous close61.62
Expiry date2024-01-19
Day's range60.74 - 60.74
Contract rangeN/A
Open interest1
  • Yahoo Finance Video

    AbbVie to acquire ImmunoGen in $10B deal

    Shares of ImmunoGen (IMGN), a biotechnology company focused on cancer treatments, surged Thursday afternoon on news that pharmaceutical giant AbbVie (ABBV) plans to acquire the company in a deal valued around $10 billion. Yahoo Finance's Diane King Hall and Josh Lipton break down the details of the deal. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.

  • Zacks

    AbbVie (ABBV) Posts Encouraging Data From Lung Cancer Study

    Data from a mid-stage study on AbbVie's (ABBV) experimental ADC drug demonstrates compelling clinical benefits across key endpoints in certain lung cancer patients.

  • Zacks

    Is it a Good Idea to Invest in Harpoon (HARP) Stock Now?

    Here, we discuss some reasons why investing in Harpoon Therapeutics (HARP) stock now may turn out to be a prudent move.